| Literature DB >> 36219270 |
Susan M Graham1, Duncan O Okall2, Supriya D Mehta3, Eve Obondi2, George Ng'ety2, Elijah Ochieng2,4, Laura Jadwin-Cakmak5, K Rivet Amico5, Gary W Harper5, Robert C Bailey2,3, Fredrick O Otieno2.
Abstract
Data on challenges with pre-exposure prophylaxis (PrEP) uptake and adherence among Kenyan gay, bisexual, and other men who have sex with men (GBMSM) are limited. In this mixed-methods sequential explanatory design study, our quantitative phase followed 157 at-risk, HIV-negative GBMSM who accepted PrEP and enrolled in a cohort with 12-month follow-up. Stored dried blood spots collected at two intervals were batch tested for tenofovir diphosphate (TFV-DP) concentrations at study end. Despite high self-reported adherence, only 14.6% of individuals had protective TFV-DP levels at any visit. Protective TFV-DP levels were positively associated with injection drug use and a self-assessed moderate risk of acquiring HIV, and negatively associated with time since enrolment. In our subsequent qualitative phase, an intensive workshop was conducted with the GBMSM community to identify barriers and facilitators to PrEP uptake and adherence. These data revealed numerous challenges with traditional PrEP programs that must be addressed through community collaborations.Entities:
Keywords: Adherence; HIV; Kenya; Men who have sex with men; Pre-exposure prophylaxis; Tenofovir disoproxil fumarate
Year: 2022 PMID: 36219270 DOI: 10.1007/s10461-022-03860-w
Source DB: PubMed Journal: AIDS Behav ISSN: 1090-7165